Published in Semin Radiat Oncol on July 01, 2003
Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst (2008) 5.05
Treatment-related cardiotoxicity in survivors of childhood cancer. Nat Rev Clin Oncol (2013) 1.07
Impact of Mindfulness-Based Stress Reduction (MBSR) on attention, rumination and resting blood pressure in women with cancer: a waitlist-controlled study. J Behav Med (2011) 1.06
Radiation as a risk factor for cardiovascular disease. Antioxid Redox Signal (2011) 1.00
p53 functions in endothelial cells to prevent radiation-induced myocardial injury in mice. Sci Signal (2012) 0.98
Medical screening participation in the childhood cancer survivor study. Arch Intern Med (2009) 0.98
Long-term survival among patients with Hodgkin's lymphoma who developed breast cancer: a population-based study. J Clin Oncol (2010) 0.96
Non-surgical therapy and radiologic assessment of stage I breast cancer treatment with novel enzyme-targeting radiosensitization: Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, type II (KORTUC II). Exp Ther Med (2010) 0.96
Cardiotoxicity in childhood cancer survivors: strategies for prevention and management. Future Cardiol (2012) 0.91
Stem cell therapies for the treatment of radiation-induced normal tissue side effects. Antioxid Redox Signal (2014) 0.90
Diabetes, diabetes treatment and breast cancer prognosis. Breast Cancer Res Treat (2014) 0.84
Noncancer-related mortality risks in adult survivors of pediatric malignancies: the childhood cancer survivor study. J Cancer Surviv (2014) 0.84
Long term cause specific mortality among 34 489 five year survivors of childhood cancer in Great Britain: population based cohort study. BMJ (2016) 0.84
Endothelial perturbations and therapeutic strategies in normal tissue radiation damage. Radiat Oncol (2014) 0.80
Association of heart block with uncommon disease States. Int J Angiol (2013) 0.78
Predicting radiation-induced valvular heart damage. Acta Oncol (2015) 0.77
Increased risk of death due to heart disease after radiotherapy for esophageal cancer. J Gastrointest Oncol (2015) 0.77
Protection against Radiotherapy-Induced Toxicity. Antioxidants (Basel) (2016) 0.75
Cardiovascular diseases related to ionizing radiation: The risk of low-dose exposure (Review). Int J Mol Med (2016) 0.75
Transcatheter Aortic Valve Implantation in a Woman with Porcelain Aorta, Previous Sternotomy for Coronary Artery Bypass Grafting, and Critical Aortic Stenosis. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2015) 0.75
Bilateral coronary ostial disease following mediastinal irradiation: a case report. Cases J (2009) 0.75
Radiation - friend or foe? Presidential address to Ulster Medical Society 4th October 2012. Ulster Med J (2014) 0.75
External beam irradiation of myocardial carcinoid metastases: a case report. J Med Case Rep (2007) 0.75
Endocrinological and cardiological late effects among survivors of childhood acute lymphoblastic leukemia. Turk J Haematol (2013) 0.75
Radiation-induced heart disease in lung cancer radiotherapy: A dosimetric update. Medicine (Baltimore) (2016) 0.75
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Maternal age and other predictors of newborn blood pressure. J Pediatr (2004) 4.78
Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol (2004) 4.63
Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA (2006) 4.51
Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma. N Engl J Med (2013) 4.49
American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol (2007) 4.45
Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys (2010) 4.33
Association between congenital cardiovascular malformations and neuroblastoma. J Pediatr (2004) 3.55
Health effects of energy drinks on children, adolescents, and young adults. Pediatrics (2011) 3.52
Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease. J Clin Oncol (2007) 3.08
Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol (2004) 2.68
Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys (2010) 2.66
Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. Blood (2006) 2.62
Systematic review and meta-analysis of circulatory disease from exposure to low-level ionizing radiation and estimates of potential population mortality risks. Environ Health Perspect (2012) 2.42
Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys (2010) 2.32
An analysis of energy-drink toxicity in the National Poison Data System. Clin Toxicol (Phila) (2013) 2.31
State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary. Circulation (2008) 2.17
Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med (2010) 2.17
Anthracycline cardiotoxicity: from bench to bedside. J Clin Oncol (2008) 2.04
Radiation-associated cardiovascular disease. Crit Rev Oncol Hematol (2003) 1.97
Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose. Int J Radiat Oncol Biol Phys (2008) 1.95
Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation. J Am Coll Cardiol (2004) 1.89
Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry. Circulation (2007) 1.86
Incidence of cardiac abnormalities in children with human immunodeficiency virus infection: The prospective P2C2 HIV study. J Pediatr (2002) 1.80
Risk factors for cardiovascular disease in children infected with human immunodeficiency virus-1. J Pediatr (2008) 1.78
Testicular cancer survivorship: research strategies and recommendations. J Natl Cancer Inst (2010) 1.76
A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425. Blood (2009) 1.74
Radiation-related heart disease: current knowledge and future prospects. Int J Radiat Oncol Biol Phys (2010) 1.72
Ingesting and aspirating dry cinnamon by children and adolescents: the "cinnamon challenge". Pediatrics (2013) 1.70
Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management. Expert Opin Pharmacother (2007) 1.68
Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies. Br J Haematol (2005) 1.68
Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: a report from the Children's Oncology Group. J Clin Oncol (2012) 1.67
The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome. Int J Radiat Oncol Biol Phys (2010) 1.65
Second malignant neoplasms and cardiovascular disease following radiotherapy. J Natl Cancer Inst (2012) 1.64
Biomarkers of vascular dysfunction in children infected with human immunodeficiency virus-1. J Acquir Immune Defic Syndr (2010) 1.62
Factors associated with establishing a causal diagnosis for children with cardiomyopathy. Pediatrics (2006) 1.59
Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients. Antimicrob Agents Chemother (2005) 1.59
Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents. Antimicrob Agents Chemother (2005) 1.57
Nicotine accelerates angiogenesis and wound healing in genetically diabetic mice. Am J Pathol (2002) 1.54
Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary. Clin Cancer Res (2003) 1.52
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer (2012) 1.49
Maternal protein intake is not associated with infant blood pressure. Int J Epidemiol (2004) 1.49
Improving normal tissue complication probability models: the need to adopt a "data-pooling" culture. Int J Radiat Oncol Biol Phys (2010) 1.44
Exercise capacity in long-term survivors of pediatric cancer: an analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study. Pediatr Blood Cancer (2012) 1.43
The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years. Heart Fail Clin (2010) 1.34
Cardiovascular trials in long-term survivors of childhood cancer. J Clin Oncol (2004) 1.32
Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: the prospective P2C2 HIV Multicenter Study. Am Heart J (2005) 1.30
Effects of environmental exposures on the cardiovascular system: prenatal period through adolescence. Pediatrics (2004) 1.29
Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. Am Heart J (2008) 1.29
Impact of HIV and highly active antiretroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis. Atherosclerosis (2005) 1.28
Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology group. J Clin Oncol (2012) 1.27
Cost-effectiveness of the children's oncology group long-term follow-up screening guidelines for childhood cancer survivors at risk for treatment-related heart failure. Ann Intern Med (2014) 1.27
Maternal calcium intake and offspring blood pressure. Circulation (2004) 1.26
Effects of HIV infection and antiretroviral therapy on the heart and vasculature. Circulation (2008) 1.25
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group. Circulation (2004) 1.25
Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane. J Clin Oncol (2008) 1.24
Pathophysiology of anthracycline- and radiation-associated cardiomyopathies: implications for screening and prevention. Pediatr Blood Cancer (2005) 1.24
Normal tissue toxicity after small field hypofractionated stereotactic body radiation. Radiat Oncol (2008) 1.21
Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study. Ann Intern Med (2012) 1.20
Neurocognitive function after radiotherapy for paediatric brain tumours. Nat Rev Neurol (2012) 1.19
Risk factors associated with secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor study. Int J Radiat Oncol Biol Phys (2012) 1.16
Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions. Transfus Med Rev (2002) 1.16
Comment on "dose-responses from multi-model inference for the non-cancer disease mortality of atomic bomb survivors" (Radiat. Environ. Biophys (2012) 51:165-178) by Schöllnberger et al. Radiat Environ Biophys (2013) 1.16
Outcome Predictors for Pediatric Dilated Cardiomyopathy: A Systematic Review. Prog Pediatr Cardiol (2007) 1.14
Cardiotoxicity after childhood cancer: beginning with the end in mind. J Clin Oncol (2010) 1.14
Associations between neurohormonal and inflammatory activation and heart failure in children. Am Heart J (2008) 1.14
Relationship between body mass index and metabolic syndrome risk factors among US 8- to 14-year-olds, 1999 to 2002. J Pediatr (2008) 1.13
Stereotactic body radiation therapy for extracranial oligometastases: does the sword have a double edge? Semin Radiat Oncol (2006) 1.13
Predictors of cardiac morbidity and related mortality in children with acquired immunodeficiency syndrome. J Am Coll Cardiol (2003) 1.12
Long-term effects of treatments for childhood cancers. Curr Opin Pediatr (2007) 1.12
Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy. J Clin Oncol (2012) 1.12
Anthracycline-associated cardiotoxicity in survivors of childhood cancer. Pediatr Cardiol (2011) 1.12
Treating children with idiopathic dilated cardiomyopathy (from the Pediatric Cardiomyopathy Registry). Am J Cardiol (2009) 1.11
The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium. Eur J Cancer (2011) 1.10
Pediatric hodgkin lymphoma: maximizing efficacy and minimizing toxicity. Semin Radiat Oncol (2007) 1.10
Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the Pediatric Cardiomyopathy Registry. Circ Heart Fail (2010) 1.10
Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber ALL Consortium Protocol 87-01. J Clin Oncol (2002) 1.07
BMI, waist circumference, and selected cardiovascular disease risk factors among preschool-age children. Obesity (Silver Spring) (2011) 1.06
Normal tissue tolerance dose metrics for radiation therapy of major organs. Semin Radiat Oncol (2007) 1.06
Early alterations in heart gene expression profiles associated with doxorubicin cardiotoxicity in rats. Cancer Chemother Pharmacol (2009) 1.04
Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry. J Am Coll Cardiol (2012) 1.02